Jo Russell
Head of Investor Relations
Replay available
Haleon plc (NYSE: HLN) Q1 2026 earnings conference call, held 2026-04-29. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, UBS
Analyst, Barclays
Analyst, Goldman Sachs
Analyst, Morgan Stanley
Analyst, JP Morgan
Analyst, Bank of America
Analyst, Jefferies
Good morning. Welcome to today's Hellion's first quarter trading update. My name is Sarah and I'll be your moderator today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you'd like to ask a question, press star one on your telephone keypad. I'd like to pass the conference over to our host, Joe Russell, head of investor relations. Please go ahead. Good morning, everyone. Welcome to Halion's Commons call for our first quarter trading statement. I am Jo Russell, Head of Investor Relations, and I'm joined this morning by Brian McNamara, our Chief Executive Officer, and Dawn Allen, our Chief Financial Officer. Just to remind listeners on the call that in the discussion today, the company may make certain forward-looking statements, including those that refer to our estimates, plans and expectations. Please refer to this morning's announcement and the company's UK and SEC filings for more details, including factors that could lead actual results to differ materially from those expressed in or implied by any such forward-looking statements. Today we'll focus on organic revenue performance. There's a full reconciliation of organic revenue in the appendix of the company's slide presentation. Following Brian and Dawn's remarks, we will take your questions. And for those listening to our webcast who would like to ask a question, you can find the details and page through today's press release. And with that, I'll hand over to Brian. Thanks, Jo, and welcome to our Q1 2026 results call. We've navigated a challenging market in the first quarter where consumer confidence continued to weaken and delivered 2.2% organic revenue growth. The continued weakness in cold and flu that we highlighted at full ye...